bcr2355 BCJ Correction <p>Correction: Genomic profiling of breast tumours in relation to <it>BRCA </it>abnormalities and phenotypes</p> Stefansson Andri Olafur oas@hi.is Jonasson Gunnlaugur Jon jongj@landspitali.is Johannsson Thor Oskar oskarjoh@landspitali.is Olafsdottir Kristrun kristrol@landspitali.is Steinarsdottir Margret margst@landspitali.is Valgeirsdottir Sigridur svlageirsdottir@nimblegen.com Eyfjord Erla Jorunn jorunne@hi.is

Faculty of Medicine, University of Iceland, Vatnsmyrarvegur 16, Reykjavik, Iceland

Department of Pathology, Landspitali University Hospital, Hringbraut, Reykjavik, 101, Iceland

Department of Oncology, Landspitali University Hospital, Hringbraut, Reykjavik, 101, Iceland

Department of Genetics and Molecular Medicine, Landspitali University Hospital, Hringbraut, Reykjavik, 101, Iceland

Roche NimbleGen, Inc., Vínlandsleið 2-4, Reykjavik, 113, Iceland

 Breast Cancer Research 1465-5411 2009 11 5 404 http://breast-cancer-research.com/content/11/5/404 1973558710.1186/bcr2355 2 9 2009 2009 BioMed Central Ltd

Following the publication of our article 1 we noticed an error in the article PDF.

Due to a production error, the final two sentences of the legend to figure 2a are incomplete. These two sentences should appear as follows:

The characters represent cluster memberships of each tumour with BRCA1 and BRCA2 abnormalities indicated, see bottom of the figure. It can be hypothesised here that component three reflects differences between BRCA1- and BRCA2-related tumours whereas component two reflects their similarities, see further in Additional data file 3.

 <p>Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes</p> Stefansson OA Jonasson JG Johannsson OT Olafsdottir K Steinarsdottir M Valgeirsdottir S Eyfjord JE Breast Cancer Research 2009 11 R47 10.1186/bcr2334 19589159